US Broker Ratings

Solventum Corporation (SOLV)

❌ Error generating article: Client error: `POST https://api.openai.com/v1/chat/completions` resulted in a `400 Bad Request` response: { “error”: { “message”: “We could not parse the JSON body..

Haleon plc (HLN) Stock Report: Exploring a 23.39% Potential Upside in the Healthcare Giant

Haleon plc (HLN), the British healthcare behemoth, commands a significant presence in the drug manufacturing sector, specializing in both specialty and generic products. With a robust..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 28% Upside Potential Lures Investors

For investors with a keen eye on the healthcare sector, Koninklijke Philips N.V. (PHG) represents a notable opportunity, particularly given its potential upside of 28.27%. As..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking the 75.67% Potential Upside for Investors

Summit Therapeutics Inc. (NASDAQ: SMMT), a key player in the biotechnology sector, has been turning heads with its remarkable market cap of $12.86 billion. The company,..

Natera, Inc. (NTRA) Stock Analysis: A Promising 41.86% Upside Potential in the Healthcare Diagnostics Sector

In the competitive landscape of the healthcare diagnostics sector, Natera, Inc. (NASDAQ: NTRA) stands out with its innovative molecular testing services and a robust growth trajectory...

United Therapeutics Corporation (UTHR)

⚠️ No article content returned.

..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 46% Potential Upside

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector specializing in medical care facilities, offers a compelling proposition for investors. Based in Birmingham,..

Bio-Rad Laboratories, Inc. (BIO) Stock Report: Exploring a 21% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a venerable name in the healthcare sector, has piqued the interest of investors with its robust potential upside. With a market..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring the 29.88% Potential Upside and Robust Dividend Yield

Novo Nordisk A/S (NVO), a titan in the healthcare sector, is making waves in the drug manufacturing industry as it continues to innovate in the fields..

Elanco Animal Health (ELAN) Stock Analysis: Impressive Revenue Growth Amidst Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) has captured the attention of investors with its dynamic position in the healthcare sector, specifically within the specialty and generic..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a Promising 79% Upside Potential

Investors eyeing opportunities in the biotechnology sector may want to consider Corcept Therapeutics Incorporated (NASDAQ: CORT), a company that stands out with its innovative approach to..

BioNTech SE (BNTX) Investor Outlook: Exploring a 53% Potential Upside Amidst Market Challenges

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its significant footprint in the healthcare industry. Headquartered in Mainz,..

Option Care Health, Inc. (OPCH) Stock Analysis: Unpacking a 47% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is a compelling player in the healthcare sector, catering specifically to the medical care facilities industry. This Illinois-based company leads..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and a 27.55% Potential Upside

Abbott Laboratories (NYSE: ABT), a cornerstone in the healthcare sector, continues to be a compelling option for investors seeking exposure to the medical devices industry. With..

Alkermes plc (ALKS) Stock Analysis: Unlocking a Potential 48% Upside Amidst Healthcare Innovation

For investors seeking opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents an intriguing prospect. This Ireland-based biopharmaceutical company, with a market cap of $4.9..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with a 12% Upside Potential

Teleflex Incorporated (NYSE: TFX), a noteworthy player in the healthcare sector, is garnering attention from investors with its promising potential upside of 12.05%. As a key..

Agilent Technologies, Inc. (A) Stock Analysis: Strong Analyst Buy Ratings Signal 48% Potential Upside

Investors eyeing Agilent Technologies, Inc. (NYSE: A) might find the current market dynamics quite compelling. With a market capitalization of $31.18 billion, Agilent operates within the..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Investors Eye a 25% Upside Potential in Biotech Innovator

Roivant Sciences Ltd. (NASDAQ: ROIV) has been catching the attention of investors with its ambitious pipeline in the biotechnology sector. Based in the United Kingdom, this..

Stevanato Group S.p.A. (STVN): Consensus Points to 87% Upside Potential for This Healthcare Innovator

Stevanato Group S.p.A. (NYSE: STVN), a leader in the healthcare sector specializing in medical instruments and supplies, is drawing attention from investors with its significant upside..

Axsome Therapeutics (AXSM) Stock Analysis: Exploring 43% Upside Potential Amid Robust CNS Pipeline

Investors with a keen interest in the biotech sector may want to keep a close eye on Axsome Therapeutics, Inc. (NASDAQ: AXSM), a company that has..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds